Pharmaceutics, Free Full-Text

The history of brain drug delivery is reviewed beginning with the first demonstration, in 1914, that a drug for syphilis, salvarsan, did not enter the brain, due to the presence of a blood–brain barrier (BBB). Owing to restricted transport across the BBB, FDA-approved drugs for the CNS have been generally limited to lipid-soluble small molecules. Drugs that do not cross the BBB can be re-engineered for transport on endogenous BBB carrier-mediated transport and receptor-mediated transport systems, which were identified during the 1970s–1980s. By the 1990s, a multitude of brain drug delivery technologies emerged, including trans-cranial delivery, CSF delivery, BBB disruption, lipid carriers, prodrugs, stem cells, exosomes, nanoparticles, gene therapy, and biologics. The advantages and limitations of each of these brain drug delivery technologies are critically reviewed.

A TEXT BOOK OF PHARMACEUTICS (D.PHARM FIRST YEAR) - Medical

SOLUTION: Unit 1 pharmaceutics b pharmacy 1st sem - Studypool

Pharmaceutical Nanotechnology: Fundamentals and Practical

15 FULL TIME Pharmaceutical Jobs! Formulator, Line Setter

Full Package Medicines Vitamins Purchase Delivery Stock Vector

PROBLEMS AND CONSTRAINTS Pharmaceuticals for Developing

Chembio3D Ultra 14.0 Free Download - Colaboratory

The British Pharmaceutical Codex : Not Available : Free Download

Pharmaceutics, Free Full-Text

Pharmaceutical Tablets and Pharmaceutical Medicines 100% Export

RePub, Erasmus University Repository: Paediatric formulations

Non-antibiotic pharmaceuticals enhance the transmission of

Pharmacy Related Text Medical Background Pharmacy Stock Vector